BioGeneration Ventures (BGV) is a venture capital firm specializing in seed investments in innovative early-stage European life sciences companies. BGV aims to co-found and invest in biotech companies developing disruptive solutions for high unmet medical needs. The firm leverages its experience from working within small and large pharma and biotech companies and its extensive industry network to bring sector-relevant expertise. They work hands-on with portfolio companies and shape them to become attractive investment opportunities within the life sciences industry. BGV's strategy focuses on accelerating product development and building companies that are attractive to larger industry players. They use their knowledge from working with universities, early-stage biotech companies, and large pharma to build companies, transform entrepreneurs, and create investment opportunities. They act as lead investors and provide operational and management expertise to review transactions.
Preferred startup development maturity for initial funding deployment.
Life Sciences, Biotechnology, Pharmaceuticals, Chronic Diseases, Hematologic malignancies (leukemia)
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...